To enable the development of our proprietary Rev-Mod platform across a broad range of therapeutic areas, we are excited to partner with established leaders in the industry. Partnerships and licensing are a key part of our commitment to address unmet needs for patients worldwide.
The Rev-Mod Platform is exclusive to RevOpsis Therapeutics with granted patents that provide strong global IP support to readily generate proprietary therapeutics in any of our Multi-Mod biologic formats. We are actively seeking partners to increase the impact of our innovative technology in the numerous races against challenging multifactorial diseases.
To learn more about partnering with RevOpsis, email us at info@revopsis.com